Abstract
Introduction

The inflammatory bowel diseases (IBD), encompassing Crohn's disease (CD) and ulcerative colitis, are chronic inflammatory disorders of the gastrointestinal tract. Current concepts of IBD pathogenesis suggest a complex interplay between genetic, nutritional and environmental factors, and gut microbiota
. Over the past decade, we, and others have reported mild to moderate hyperhomocysteinemia in the plasma of patients with IBD [3, 4] . Markedly elevated concentrations of homocysteine were also found in the colonic mucosa of IBD patients [5, 6] . Hyperhomocysteinaemia should only be considered a surrogate marker for methyl donor deficiency. Homocysteine plasma level is mainly influenced by nutritional status in folate, vitamin B12, vitamin B6 and by genetic polymorphisms of key enzymes of its metabolism [4] . Vitamin B12 and methylenetetrahydrofolate reductase 677TT genotype may be the main determinants of hyperhomocysteinemia in CD patients [3] .
Methyl donor deficiency (folate and/or vitamin B12 deficiency) leads to increased homocysteine in tissues and might promote mucosal inflammation by activating a wide range of pathways related with inflammation, cellular and oxidative stress and apoptosis [4] . Homocysteine can induce the production of several inflammatory cytokines and chemokines, including the monocyte chemoattractant protein-1 (MCP-1, also termed CCL2) and interleukin (IL)-8 [5, 7] . Homocysteine [8] . Elevated homocysteine levels were also shown to enhance superoxide dismutase (SOD) activity, a well-established marker of oxidative stress [9, 10] . We recently showed that the level of SOD was significantly correlated with Crohn's Disease Activity Index (DAI) in CD patients carrying methionine synthase reductase MTRR AA genotype [3] . Methyl donor deficiency affects the cell organization and function in the gastric mucosa of rat [11] . Apoptosis of T-cells has a key role in the pathophysiology of IBD [12] . A disturbed ratio between proapoptotic and anti-apoptotic pathways was shown to mediate apoptosis resistance in patients with CD [13] . By modulating apoptotic pathways [14] , methyl donor status might contribute to intestinal homeostasis [4] .
pro-inflammatory molecules requires NF-B (nuclear factor-kappa B) activation, a crucial transcription factor involved in mediating downstream inflammatory process
Despite 
Materials and methods
Animals, diet and induction of colitis
Animal experiments were performed in accredited establishments (Inserm U 954) [17] . We measured the activity of myeloperoxidase in colon samples, using the method previously described by Xia and Zweier [18] . 
Quantification of mRNA of tumour necrosis factor (TNF)-␣ by Q-RT-PCR
Results
Confirmation of methyl donor deficiency
Effects of methyl donor deficiency during DSS-induced colitis
Treatment with DSS induced a colitis characterized by inflammatory cell infiltrations, as previously described [20, 21] 
Inflammatory mediators and pathways
The mRNA level of TNF-␣ was determined by semi-quantitative real time RT-PCR, using PR29 (Ribosomal protein 29) as reference gene. The TNF-␣ mRNA level was significantly higher in colon from methyl-deficient rats compared to the rats fed a standard diet (Fig. 3). In line with the increased expression of TNF-␣, Western blot analysis showed a decreased expression of TIMP3, a potent inhibitor of TNF-␣ in rats subjected to DSS and/or the MDD, compared with control animals. By contrast, expression levels of TACE were broadly similar between the four groups (Fig. 3). Western blot analysis revealed that the expression level of p38 was markedly increased by the MDD in the absence of DSS treatment (Fig. 4). The MDD dramatically increased the p38 protein level in DSS-treated rats, compared to animals receiving DSS alone (C/DSS
ϩ group) (Fig. 4) . [23] . Arachidonic acid is then converted into eicosanoids by three enzymes, namely COX, LOX and cytochrome P450 [23, 24] . To further evaluate the consequences of the increase in cPLA2 expression during MDD and experimental colitis, the protein levels of COX-1, COX-2 and 5-LOX were measured in the colon of rats [23] . As showed in Figure 6, 
The MDD also increased the expression of cPLA2 in the rats treated with DSS (Fig. 4). Immunohistochemistry confirmed an increased expression of cPLA2 in the colon of rats fed a MDD compared with animals of the control group, in absence of DSS treatment (Fig. 5). Histopathological examination of the mucosa of the deficient animals treated by DSS showed necrotic lesions in the glands, an oedema and an infiltration by mononuclear cells in the sub-mucosa. The vessels were dilated and shared thrombotic lesions (Fig. 5). The mucosal damage produced by DSS did not allow evaluating the expression of cPLA2 by immunohistochemistry in the DSS-treated animals. Arachidonic acid is released from membrane phospholipids by cPLA2
Integrity of the intestinal barrier
Fig. 4 Effects of MDD on expression levels of p38 and cPLA2 during DSSinduced colitis in rats. Western blot analysis of p38 and cPLA2 expression (top) and quantitative analysis (bottom). *p38 and cPLA2 of C DSS
01). The absence of influence of the methyl donor deficiency on mucosal integrity was also demonstrated by the maintained expression of ␤-catenin and the absence of MPO in immunohistochemical examination of colon specimens from D DSS
Ϫ rats, compared with C DSS Ϫ rats (Fig. 7) . In agree- 
Discussion
We recently demonstrated in rats that methyl donor deficient diet during gestation and lactation induced gastric lesions at weaning characterized by surface layer erosion related with loss of cell polarity, anarchic cell migration, abnormal progenitor differentiation and apoptosis [25] . Herein, we found that this MDD was not capable of increasing the DAI, in the absence of any additional exposure. We were willing to investigate whether the pro-inflammatory 
Immunohistochemistry of cPLA2 in colonic mucosa of control (C) and deficient rats (D). Immunohistochemistry of COX2 in colonic mucosa of control (E) and methyl-deficient rats (F). Data shown are representative of triplicate experiments and magnifications are indicated by bars. pathways and the surface layer erosion specifically activated by the methyl donor deficiency aggravate the mucosal injury produced by DSS, because the latter is a widely used non soluble agent that disrupts the colonic epithelium.
A decrease in antioxidant capacity associated with an increased oxidative stress has been reported in CD patients [26] . In our model, the methyl deficiency diet led to a significant increase in SOD in the absence of DSS administration. This result is in line with the study by Moat et al. showing enhanced activity of SOD in the plasma of patients with hyperhomocysteinemia [9] . Consistently, we recently found a significant association between clinical activity and the SOD activity in CD patients carrying the MTRR 66AA genotype [3] . The effect of homocysteine on GPX activity remains controversial [9, 27] . This may be partly explained by differences between the models studied (human beings, animals, or cell culture). In our study, a MDD did not affect GPX activity, suggesting that SOD rather than GPX may mediate oxidative stress in the colon of rats and contribute to pathological intestinal inflammation.
An increased Bcl2 : Bax ratio resulting in resistance of T cells against apoptosis has been reported in the lamina propria of CD patients [12, 13] . We found that DSS-induced colitis enhanced the expression of the anti-apoptotic factor Bcl2 while decreasing the level of pro-apoptotic markers (capsase-3 and Bax) in rats fed the [14, 28] , whereas the expression level of pro-apoptotic markers was increased in the liver from cystathionine ␤ synthase-deficient mice, brain from methyl-deficient rats or in rats restricted in folate and vitamin E [28] [29] [30] [31] [33] . These and our data therefore suggest investigating whether TIMP3 exerts regulating effects on the TNF-␣ pathway by dual mechanisms, the one dependent and the other independent from TACE [34] . Activation of p38 MAPK has been linked to IBD pathogenesis [35] . In line with previous reports showing that homocysteine can activate p38 [5] , which in turn increases TNF levels [36] , both p38 and TNF expression levels were significantly increased in the colon of rats fed a MDD. Pro-inflammatory stimuli, such as TNF, are well-established inducers of anti-apoptotic pathways [12] . Accordingly, the expression of Bax, an anti-apoptotic factor, is down-regulated in inflamed colonic mucosa of IBD patients [37] . Vitamin B12 deficiency is associated with increased TNF levels and TNF-related pathways in cell models, in human beings and in rats [38] [39] [40] [24] . When tissues are exposed to these stimuli, arachidonic acid is released from membrane phospholipids by phospholipases, cPLA2 being the key enzyme in eicosanoid production [24] . Arachidonic acid is then converted into eicosanoids by three enzymes, namely COX, LOX and cytochrome P450 [24] . The activity of cPLA2 was markedly increased in the colon of rats treated with DSS [42] . The concentration of cPLA2 was also increased in colonic mucosa of patients with active IBD [43] . Accordingly, cPLA2 inhibition had an antiinflammatory effect during experimental colitis in rats [43] . In the absence of colitis, we found that methyl donor deficiency was associated with an increase in cPLA2 levels in the rat colon. Similar to apoptosis, the increase in p38 levels associated with MDD may contribute to high cPLA2 in these animals, as suggested by previous reports [21] [22] [23] . Therefore, a MDD may further enhance colonic lesions induced by DSS treatment in rats.
MDD. Homocysteine treatment was shown to induce apoptosis of different cell types in vitro
COX and LOX are two enzymes responsible for the synthesis of eicosanoids, using arachidonic acid as substrate [24] . Two COX isoforms have been identified, COX-1, the constitutive form and COX-2, the inducible form [24] . The expression of 5-LOX and COX-1 was unchanged in the colon of IBD patients [44] [49] . The decreased expression of pro-apoptotic markers in colon mucosa of the deficient animals has also to be considered in regards to the controversy that exists between the folate status and the risk for colon cancer [50] [51] [52] 
